Rchr
J-GLOBAL ID：202201010453346419
Update date: Sep. 05, 2024
Suzuki Shinichiro
スズキ シンイチロウ | Suzuki Shinichiro
Affiliation and department：
Job title：
Assistant professor
Research theme for competitive and other funds (2)：
- 2022 - 2025 Analysis of the risk factors for the development and severity of immune-related adverse events by immune checkpoint inhibitors
- 2021 - 2025 Exploring mechanism underlying resistance to kras inhibitor
Papers (19)：
-
高濱 隆幸, 米阪 仁雄, 谷崎 潤子, 田中 薫, 鈴木 慎一郎, 金村 宙昌, 磯本 晃佑, 白石 直樹, 坂井 和子, 福岡 和也, et al. 分子標的治療とprecision medicine 肺癌に対する遺伝子パネル検査の実際と出口戦略の検討. 肺癌. 2023. 63. 5. 372-372
-
Seiichiro Mitani, Hisato Kawakami, Osamu Shiraishi, Hiroaki Kanemura, Shinichiro Suzuki, Koji Haratani, Hidetoshi Hayashi, Kimio Yonesaka, Yasutaka Chiba, Takushi Yasuda, et al. Implication of changes in PD-L1 expression during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF) regimen in esophageal squamous cell carcinoma. Esophagus : official journal of the Japan Esophageal Society. 2023. 20. 2. 281-289
-
Seiichiro Mitani, Hisato Kawakami, Osamu Shiraishi, Hiroaki Kanemura, Shinichiro Suzuki, Koji Haratani, Hidetoshi Hayashi, Kimio Yonesaka, Yasutaka Chiba, Takushi Yasuda, et al. Correction: Implication of changes in PD-L1 expression during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF) regimen in esophageal squamous cell carcinoma. Esophagus : official journal of the Japan Esophageal Society. 2023. 20. 2. 290-290
-
Takashi Kurosaki, Kenji Chamoto, Shinichiro Suzuki, Hiroaki Kanemura, Seiichiro Mitani, Kaoru Tanaka, Hisato Kawakami, Yo Kishimoto, Yasuharu Haku, Katsuhiro Ito, et al. The combination of soluble forms of PD-1 and PD-L1 as a predictive marker of PD-1 blockade in patients with advanced cancers: a multicenter retrospective study. Frontiers in immunology. 2023. 14. 1325462-1325462
-
米阪 仁雄, 高濱 隆幸, 黒崎 隆, 川中 雄介, 金村 宙昌, 磯本 晃佑, 鈴木 慎一郎, 三谷 誠一郎, 中川 和彦, 白石 直樹, et al. がん遺伝子パネル検査FoundationOneによる肺癌の遺伝子変異の測定. 肺癌. 2022. 62. 5. 439-439
ｍore...
MISC (3)：
-
鈴木慎一郎, 大倉將生, 川中雄介, 金村宙昌, 磯本晃佑, 高濱隆幸, 田中薫, 林秀敏. EBUS-GSのガイドシースの先端マーカーが気管内に脱落した1例. 気管支学. 2024. 46. 2
-
金村 宙昌, 竹原 俊幸, 小野寺 勇太, 寺村 岳士, 鈴木 慎一郎, 坂井 和子, 西尾 和人, 中川 和彦, 林 秀敏, 米阪 仁雄. PTPRRを介したEGFR活性化に起因するKRASG12C阻害薬耐性の克服(Combating acquired resistance to KRAS inhibitors in NSCLC by targeting PTPRR-mediated activation of EGFR signaling). 日本癌学会総会記事. 2023. 82回. 422-422
-
米阪仁雄, 稲垣千昌, 稲垣千昌, 高濱隆幸, 高濱隆幸, 白石直樹, 磯本晃佑, 金村宙昌, 鈴木慎一郎, 谷崎潤子, et al. Providing Anti-Lung Cancer Drug Therapy Based on Genetic Information by Comprehensive Genomic Profiling. 日本癌学会学術総会抄録集(Web). 2023. 82nd
Professional career (1)：
- PhD. M.D. (Kindai University)
Return to Previous Page
